Back to NewsPublished: 16 Feb 2026Download AppJoin TelegramWhy Eris Lifesciences’ EBITDA Slip Could Signal a Bigger Upside for Investors#Eris Lifesciences#Pharma#EBITDA#India Healthcare#Insulin Market#GLP-1#Derma#InvestmentDownload AppJoin CommunityShare Article